CMD Bioscience introduces its peptide research and discovery platform: CMDInventusSM
CMDInventusSM our computational biotechnology platform provides a powerful and elegant solution to the problem of novel peptide discovery and design. Our computational biotechnology platform has been designed from the ground up to minimize risk and facilitate computational peptide drug design.
CMDInventusSM incorporates our proprietary work-flow for analyzing, modeling and optimizing protein and peptide structures, our de novo peptide ligand design algorithm, our proprietary peptide docking and virtual screening work-flows.
CMDSolvationSM is our cutting-edge computational method for predicting the water-membrane partitioning behavior of peptides and proteins. This is a key capability for successful peptide discovery.
In sum, our scoring methodologies, our phase partitioning function, our docking and virtual screening underpin CMDInventusSM our peptide drug discovery computational platform for Peptide Research.